A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive

NCT00264537 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

637

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Placebo injections
DRUG: Placebo capsules
DRUG: Methotrexate capsules
BIOLOGICAL: Golimumab 50 mg injections
BIOLOGICAL: Golimumab 100 mg injections

Sponsor

Centocor, Inc.

Collaborators

[object Object]